Serum HER-2/neu as a prediction and monitoring parameter in a phase II study with weekly paclitaxel in metastatic breast cancer.
Year: 2004
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Diana Lüftner, Petra Henschke, Bernd Flath, Costa Akrivakis, Sonja Schnabel, Berit Prinz, Rita Geppert, Klaus-Dieter Wernecke, Kurt Possinger
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2138856635